Harbin Pharmaceutical Group Co Ltd (HPGC) is a pharmaceutical company that focuses on the research and development, manufacturing and commercialization of pharmaceutical products. It provides antibiotics, OTC and healthcare products, traditional and modern Chinese medicine, biomedicine, pharmaceutical and animal vaccines business. The company’s product portfolio includes calcium gluconate oral solution, zinc gluconate oral solution, pediatric paracetamol, lacidipine tablets, penicillin sodium for injection and amoxicillin capsules, among others. HPGC manufactures products in therapeutic areas such as anti-infection, cardiovascular and cerebrovascular, cold medicine, digestive system, anti-tumor drugs and nutritional supplements. HPGC is headquartered in Harbin, Heilongjiang, China.
Harbin Pharmaceutical Group Co Ltd premium industry data and analytics
Products and Services
Products |
---|
Product: |
Calcium Gluconate Oral Solution |
Zinc Gluconate Oral Solution |
XYZ |
XYZ |
XYZ |
Competitor Comparison
Key Parameters | Harbin Pharmaceutical Group Co Ltd | Shenzhen Neptunus Bioengineering Co Ltd | Huadong Medicine Co Ltd | Shandong Buchang Pharmaceutical Co Ltd | KPC Pharmaceuticals Inc |
---|---|---|---|---|---|
Headquarters | China | China | China | China | China |
City | Haerbin | Shenzhen | Hangzhou | Heze | Kunming |
State/Province | Heilongjiang | Guangdong | Zhejiang | Shandong | Yunnan |
No. of Employees | 9,853 | 9,874 | 14,061 | 8,491 | 5,051 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Zhang Yichen | Chairman | Executive Board | 2021 | 60 |
Hu Xiaoping | Vice Chairman | Executive Board | 2022 | 53 |
Liu Bo | Deputy General Manager; Chief Financial Officer | Senior Management | 2015 | 60 |
Jiang Haitao | Deputy General Manager | Senior Management | 2022 | 41 |
Meng Xiaodong | Deputy General Manager; Secretary | Senior Management | 2010 | 51 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer